Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and …
![Researchers working in a laboratory setting, symbolizing collaboration and scientific research for cancer treatment.](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-tara-winstead-7723193-scaled.jpg?resize=760%2C427&ssl=1)
![Researchers working in a laboratory setting, symbolizing collaboration and scientific research for cancer treatment.](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/03/pexels-tara-winstead-7723193-scaled.jpg?resize=760%2C427&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and …
Biotheus Inc. (Biotheus), a clinical-stage biotech company focusing on the discovery and development of biologics …
Johnson & Johnson (NYSE: JNJ) announced today that following a priority review, the U.S. Food and …
Jacobio Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced it received …
Dragonfly Therapeutics, Inc., a clinical-stage biotechnology company developing novel immunotherapies, today announced a new clinical …
Johnson & Johnson announced today the submission of a supplemental Biologics License Application (sBLA) to …